Disease Areas
News and analysis on disease research and diagnostics.
UK Government Extends Authorization for Innova Medical SARS-CoV-2 Antigen Test
The UK government has extended the timeline of its Exceptional Use Authorization for the Innova lateral flow test, though the FDA has warned about its performance.
Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test
The Cobas test is the first molecular, point-of-care test to receive Emergency Use Authorization for asymptomatic people.
Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test
SARS-CoV-2 testing has become a major part of Co-Diagnostics' business, accounting for the lion's share of the company's revenues recently.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.
LumiraDx Gets CE Mark for POC, Pooled Sample SARS-CoV-2 Antigen Test
The company last year received FDA Emergency Use Authorization for a PCR-based SARS-CoV-2 that does not require nucleic acid purification or extraction.